Bailard’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q2
Sell
-19,800
Closed -$1.29M 259
2014
Q1
$1.29M Sell
19,800
-4,530
-19% -$294K 0.2% 72
2013
Q4
$1.37M Buy
24,330
+12,000
+97% +$676K 0.22% 69
2013
Q3
$756K Hold
12,330
0.14% 117
2013
Q2
$721K Buy
+12,330
New +$721K 0.13% 122